In addition to the annual Highlights report, MAX IV releases a new report focusing on the industrial utilisation of the facility.
The drug discovery company Implexion Pharma and researchers from Lund University have explored new potential drug candidates for type 2 diabetes using X-ray crystallography research techniques at MAX IV.
In the battle against cancer, scientists from the drug discovery company Sprint Bioscience and researchers from MAX IV have taken important steps together toward developing new and more efficient cancer drugs with the help of fragment screening by X-ray crystallography.
The newest research station at MAX IV, ForMAX, has hosted its first industry experiment: A ground-breaking study on fibre-based sustainable food packaging, performed by Tetra Pak in collaboration with Chalmers University of Technology.
Metal cutting tool company Seco Tools and researchers from Linköping University have studied structural changes in TiAlN coatings on tools in atomic detail at the MAX IV beamline Balder. The results will guide the company’s development of more efficient metal-cutting tools.
ForMAX, the newest beamline at MAX IV, is now officially open for experiments. The focus will be research on new, sustainable materials from the forest, but the beamline will also be useful for research in many other fields and industries, including food, textiles, and life science.
The quest for tastier, more sustainable vegan cheese has led Swedish food company Cassius AB to take a closer look at cheese protein structures. Using synchrotron X-rays at MAX IV, Cassius are searching for the perfect scientific recipe for plant-based cheese.